150 related articles for article (PubMed ID: 8085851)
1. [Innate resistance to thymidylate synthase inhibition after 5-fluorouracil treatment--a rationale of combined use of cisplatin and its optimal administration dose].
Omura K; Hashimoto T; Kawakami K; Kanehira E; Watanabe T; Hirano K; Watanabe S; Watanabe Y; Shirasaka T
Gan To Kagaku Ryoho; 1994 Sep; 21(12):2007-11. PubMed ID: 8085851
[TBL] [Abstract][Full Text] [Related]
2. [Drug concentration in cancerous large bowel tissue and thymidylate synthase inhibition rate after administration of tegafur and UFT].
Futami K; Arima S; Yoshimura S; Okamoto T; Yamasaki K; Koto T; Yamasaki S; Kawahara K; Ikuno T
Gan To Kagaku Ryoho; 1991 Feb; 18(2):215-20. PubMed ID: 1992915
[TBL] [Abstract][Full Text] [Related]
3. [Level of inhibition of thymidylate synthase activity and 5-fluorouracil in tumor tissues after administration of UFT or tegafur].
Suzuki M; Sekiguchi I; Tamada T; Nishida M
Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1399-404. PubMed ID: 2530293
[TBL] [Abstract][Full Text] [Related]
4. [UFT/CDDP preoperative chemotherapy for progressive gastric cancer--histological antitumor effects and thymidylate synthase inhibition rate].
Tanaka S; Umeno T; Mitsuishi K; Tomita A; Ootsuka K; Mori H; Nakamura H; Ikeda S
Gan To Kagaku Ryoho; 1995 Nov; 22(13):1947-51. PubMed ID: 7487125
[TBL] [Abstract][Full Text] [Related]
5. [Comparison between leucovorin and cisplatin as a modulator of 5-fluorouracil].
Iba T; Yagi Y; Kidokoro A; Fukunaga T
Gan To Kagaku Ryoho; 1993 Mar; 20(4):479-83. PubMed ID: 8452385
[TBL] [Abstract][Full Text] [Related]
6. [Thymidylate synthase inhibition and concentration of 5-fluorouracil after administration of UFT in human uroepithelial carcinomas].
Kanimoto Y; Suzuki Y; Miwa Y; Akino H; Isomatu Y; Okada K
Hinyokika Kiyo; 1991 Mar; 37(3):229-33. PubMed ID: 1648873
[TBL] [Abstract][Full Text] [Related]
7. [Studies on the mechanism of antitumor activity of 5-FU and its derivatives--relationship between the inhibition of tumor growth and the inhibition of thymidylate synthetase in vivo].
Nakamura H; Yu-Qin W; Miyauchi S; Nishioka N; Tanaka H; Harada N; Shirasaka T; Fujii S
Gan To Kagaku Ryoho; 1984 May; 11(5):1049-55. PubMed ID: 6426401
[TBL] [Abstract][Full Text] [Related]
8. [Antitumor activity and function of S-1, a new oral tegafur-based formulation].
Fukushima M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():19-26. PubMed ID: 16897968
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism for synergistic antitumor effect in the combination of 5-fluorouracil with cisplatin in vivo tumor models: from the view of biochemical modulation of 5-fluorouracil].
Shirasaka T; Shimamoto Y; Ohshimo H; Kimura A; Fukushima M
Gan To Kagaku Ryoho; 1991 Mar; 18(3):403-9. PubMed ID: 2003740
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide augments the anti-tumor efficacy of uracil and tegafur by inhibiting dihydropyrimidine dehydrogenase.
Nio Y; Iguchi C; Kodama H; Itakura M; Hashimoto K; Koike M; Toga T; Maruyama R; Fukushima M
Oncol Rep; 2007 Jan; 17(1):153-9. PubMed ID: 17143493
[TBL] [Abstract][Full Text] [Related]
11. A potential important role for thymidylate synthetase inhibition on antitumor activity of fluoropyrimidine and raltitexed.
Kabeshima Y; Kubota T; Watanabe M; Saikawa Y; Nishibori H; Hasegawa H; Kitajima M
Anticancer Res; 2002; 22(6A):3245-52. PubMed ID: 12530071
[TBL] [Abstract][Full Text] [Related]
12. Relationship of in vivo antitumor activities of fluorinated pyrimidines to thymidylate synthase activity and intratumoral concentrations of 5-fluorouracil and uracil.
Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Kawabata K; Imai S; Tobe T
Anticancer Res; 1991; 11(2):607-12. PubMed ID: 2064315
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between antitumor activity and the inhibition of thymidylate synthase after oral administration of UFT in nude mice bearing human tumor].
Fujita M; Fujita F; Uchida J; Takeda S; Yamada Y; Taguchi T
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):627-32. PubMed ID: 2108611
[TBL] [Abstract][Full Text] [Related]
14. [Thymidylate synthase inhibition in malignant tumors after oral administration of UFT].
Yamamura M; Seiro T; Yamamoto M; Shirasaka T; Miyauchi S; Fujii S
Gan No Rinsho; 1986 Nov; 32(14):1838-40. PubMed ID: 3099031
[TBL] [Abstract][Full Text] [Related]
15. Schedule-dependent synergism of vinorelbine and 5-fluorouracil/UFT against non-small cell lung cancer.
Matsumoto S; Igishi T; Hashimoto K; Kodani M; Shigeoka Y; Nakanishi H; Touge H; Kurai J; Makino H; Takeda K; Yasuda K; Hitsuda Y; Shimizu E
Int J Oncol; 2004 Nov; 25(5):1311-8. PubMed ID: 15492820
[TBL] [Abstract][Full Text] [Related]
16. Preliminary study of the optimal dosing schedule for oral UFT/leucovorin chemotherapy.
Sadahiro S; Suzuki T; Ishikawa K; Nakamura T; Saguchi T; Kamijo A; Yasuda S; Makuuchi H; Murayama C
Anticancer Res; 2004; 24(2B):625-30. PubMed ID: 15161004
[TBL] [Abstract][Full Text] [Related]
17. [Study of preoperative combination therapy with UFT + CDDP in patients with gastric and colorectal cancer--concomitant effects based on the thymidylate synthase inhibitory rat].
Mitsuishi K; Umeno T; Tanaka S; Kimura H; Fuchino Y; Tomita A; Ikeda S
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1119-24. PubMed ID: 9239165
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
[TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase polymorphism is associated with folate pool in gastrointestinal cancer tissue.
Kawakami K; Omura K; Kanehira E; Watanabe G
Anticancer Res; 2001; 21(1A):285-9. PubMed ID: 11299748
[TBL] [Abstract][Full Text] [Related]
20. Effects of UFT on thymidylate synthase and dihydropyrimidine dehydrogenase activities in lung cancer.
Miyamoto H; Morio A; Izumi H; Yamazaki A; Wang Z; Futagawa T; Sonobe S
Anticancer Res; 2003; 23(5b):4153-6. PubMed ID: 14666617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
